These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 8295285

  • 1. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G, Mogensen CE, Groop LC, Pauls JF.
    JAMA; 1994 Jan 26; 271(4):275-9. PubMed ID: 8295285
    [Abstract] [Full Text] [Related]

  • 2. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov 26; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
    Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW.
    J Pediatr; 1990 Jul 26; 117(1 Pt 1):39-45. PubMed ID: 2196359
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
    Mathiesen ER, Hommel E, Giese J, Parving HH.
    BMJ; 1991 Jul 13; 303(6794):81-7. PubMed ID: 1860008
    [Abstract] [Full Text] [Related]

  • 5. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 6. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun 21; 349(9068):1787-92. PubMed ID: 9269212
    [Abstract] [Full Text] [Related]

  • 7. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May 21; 39(5):587-93. PubMed ID: 8739919
    [Abstract] [Full Text] [Related]

  • 8. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group.
    Trevisan R, Tiengo A.
    Am J Hypertens; 1995 Sep 21; 8(9):876-83. PubMed ID: 8541002
    [Abstract] [Full Text] [Related]

  • 9. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 10. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ, Ramos OL, Gross JL.
    Horm Metab Res; 1997 Oct 07; 29(10):516-9. PubMed ID: 9405980
    [Abstract] [Full Text] [Related]

  • 11. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G, Giustina A, Cravarezza P, Caldonazzo A, Agabiti-Rosei E, Giustina G.
    J Hum Hypertens; 1991 Jun 07; 5(3):167-73. PubMed ID: 1920340
    [Abstract] [Full Text] [Related]

  • 12. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1995 Oct 14; 311(7011):973-7. PubMed ID: 7580637
    [Abstract] [Full Text] [Related]

  • 13. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
    Hansen KW, Klein F, Christensen PD, Sørensen K, Andersen PH, Møller J, Pedersen EB, Christiansen JS, Mogensen CE.
    Diabete Metab; 1994 Oct 14; 20(5):485-93. PubMed ID: 7859897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M.
    Ann Intern Med; 1993 Apr 15; 118(8):577-81. PubMed ID: 8452322
    [Abstract] [Full Text] [Related]

  • 18. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J, Siddiqui MA, Ahmad H.
    Diabetes Care; 1997 Oct 15; 20(10):1576-81. PubMed ID: 9314638
    [Abstract] [Full Text] [Related]

  • 19. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
    Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J, DIABHYCAR Study Investigators.
    BMJ; 2004 Feb 28; 328(7438):495. PubMed ID: 14960504
    [Abstract] [Full Text] [Related]

  • 20. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS.
    Clin J Am Soc Nephrol; 2007 May 28; 2(3):461-9. PubMed ID: 17699452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.